Scinai Immunotherapeutics Management
Management criteria checks 3/4
Scinai Immunotherapeutics' CEO is Amir Reichman, appointed in Mar 2021, has a tenure of 3.42 years. total yearly compensation is $927.00K, comprised of 56.1% salary and 43.9% bonuses, including company stock and options. directly owns 0.29% of the company’s shares, worth €9.00K. The average tenure of the management team and the board of directors is 4.2 years and 4.4 years respectively.
Key information
Amir Reichman
Chief executive officer
US$927.0k
Total compensation
| CEO salary percentage | 56.1% |
| CEO tenure | 3.4yrs |
| CEO ownership | 0.3% |
| Management average tenure | 4.2yrs |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$4m |
| Mar 31 2024 | n/a | n/a | -US$5m |
| Dec 31 2023 | US$927k | US$520k | -US$6m |
| Sep 30 2023 | n/a | n/a | -US$9m |
| Jun 30 2023 | n/a | n/a | -US$8m |
| Mar 31 2023 | n/a | n/a | -US$7m |
| Dec 31 2022 | US$1m | US$368k | -US$6m |
| Sep 30 2022 | n/a | n/a | -US$8m |
| Jun 30 2022 | n/a | n/a | -US$8m |
| Mar 31 2022 | n/a | n/a | -US$8m |
| Dec 31 2021 | US$1m | US$664k | -US$8m |
Compensation vs Market: Amir's total compensation ($USD927.00K) is above average for companies of similar size in the German market ($USD540.72K).
Compensation vs Earnings: Amir's compensation has been consistent with company performance over the past year.
CEO
Amir Reichman (48 yo)
3.4yrs
Tenure
US$927,000
Compensation
Mr. Amir Reichman M.Sc, M.B.A, has been the Chief Executive Officer at Scinai Immunotherapeutics Ltd. (formerly known as BiondVax Pharmaceuticals Ltd.) since March 02, 2021 and has been its Director since...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.4yrs | US$927.00k | 0.29% $ 9.0k | |
| Chief Financial Officer | 17.6yrs | US$174.00k | no data | |
| Chief Operating Officer | 4.9yrs | US$265.00k | no data | |
| Chief Technology Officer | less than a year | US$232.00k | no data | |
| Chief Scientist | 20.6yrs | US$297.00k | no data | |
| Head of Business Development & Sales | less than a year | no data | no data | |
| Head of Quality Control | no data | no data | no data |
4.2yrs
Average Tenure
53yo
Average Age
Experienced Management: 2F5's management team is considered experienced (4.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3.5yrs | US$927.00k | 0.29% $ 9.0k | |
| Independent Director | 4.4yrs | US$92.19k | 0.0063% $ 198.7 | |
| Independent Director | 6.8yrs | US$78.79k | 0.0039% $ 123.9 | |
| Independent Director | 4.4yrs | US$87.02k | 0.0039% $ 123.9 | |
| Chairman of the Board | 6.2yrs | US$336.67k | 0% $ 0 | |
| Head of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | US$68.36k | 0.013% $ 393.6 | |
| Independent Director | 2.6yrs | US$76.59k | 0.0081% $ 255.0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Director | 4.4yrs | US$493.15k | 0% $ 0 | |
| Independent Director | 2.7yrs | US$72.36k | 0.0025% $ 78.6 | |
| Member of Scientific Advisory Board | 1.7yrs | no data | no data |
4.4yrs
Average Tenure
71yo
Average Age
Experienced Board: 2F5's board of directors are considered experienced (4.4 years average tenure).